Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...
A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...
The Swiss pharmaceutical giant said Wednesday that the trial compared a high dose of Ocrevus intravenous infusion to the currently approved Ocrevus IV 600 mg dose in people with relapsing multiple ...
Multiple sclerosis is a long-term disease that damages the brain and spinal cord. It happens when the immune system attacks ...
At one point during her health journey, Chandler resident Erin Kienlen thought she had amyotrophic lateral sclerosis, or ALS.
A new study from researchers in France has found that taking high doses of vitamin D every two weeks may help reduce disease ...
March is regonized as multiple sclerosis awareness month. One woman is shining a light on MS and sharing a message of hope ...
With the UAE now considered a moderately high-risk zone for multiple sclerosis, Snap’s first step counter lens is being used to raise awareness for the condition.
A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...
Or, MD, a distinguished researcher and neurologist at Penn Medicine, is the winner of the 2025 John Dystel Prize for Multiple ...
Experts at Care UK have flagged that being unable to make decisions could be an early indicator of dementia, stressing a number of the disease's initial symptoms. Many might overlook such early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback